Ionis Pharmaceuticals (IONS) Other Operating Expenses (2010 - 2026)

Ionis Pharmaceuticals' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $2.7 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 34.02% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $16.0 million (up 52.34% YoY), while the FY2025 annual figure was $15.9 million, up 132675.0% from the prior year.
• Other Operating Expenses for Q2 2026 stood at $2.7 million, down from $3.0 million in the prior quarter.
• The five-year high for Other Operating Expenses was $756.8 million in Q4 2022, with the low at $1.1 million in Q3 2024.
• The 5-year median for Other Operating Expenses is $2.9 million (2026), against an average of $45.0 million.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses sank 99.6% in 2023, then jumped 118.3% in 2025.
• Ionis Pharmaceuticals' Other Operating Expenses stood at $756.8 million in 2022, then tumbled by 99.6% to $3.1 million in 2023, then rose by 25.09% to $3.8 million in 2024, then surged by 107.81% to $8.0 million in 2025, then sank by 65.58% to $2.7 million in 2026.
• Business Quant data shows IONS's Other Operating Expenses at $2.7 million in Q2 2026, $3.0 million in Q1 2026, and $8.0 million in Q4 2025.